Aspects of the general biology of adenosine A2A signaling
暂无分享,去创建一个
[1] R. Lefkowitz,et al. Seven transmembrane receptors: something old, something new , 2007, Acta physiologica.
[2] A. Ohta,et al. A2A adenosine receptor protects tumors from antitumor T cells , 2006, Proceedings of the National Academy of Sciences.
[3] Seiko F. Okada,et al. Physiological Regulation of ATP Release at the Apical Surface of Human Airway Epithelia*♦ , 2006, Journal of Biological Chemistry.
[4] Y. Chern,et al. Rescue of p53 Blockage by the A2A Adenosine Receptor via a Novel Interacting Protein, Translin-Associated Protein X , 2006, Molecular Pharmacology.
[5] J. Linden. New insights into the regulation of inflammation by adenosine. , 2006, The Journal of clinical investigation.
[6] M. Koupenova,et al. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. , 2006, The Journal of clinical investigation.
[7] K. Fuxe,et al. The Two-State Dimer Receptor Model: A General Model for Receptor Dimers , 2006, Molecular Pharmacology.
[8] A. Zernecke,et al. CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation , 2006, Circulation.
[9] M. Freissmuth,et al. The Ubiquitin-Specific Protease Usp4 Regulates the Cell Surface Level of the A2a Receptor , 2006, Molecular Pharmacology.
[10] M. Postow,et al. Tumor Necrosis Factor-α Prevents Desensitization of Gαs-Coupled Receptors by Regulating GRK2 Association with the Plasma Membrane , 2006, Molecular Pharmacology.
[11] A. Fortin,et al. Differential expression of adenosine receptors in human neutrophils: up‐regulation by specific Th1 cytokines and lipopolysaccharide , 2006, Journal of leukocyte biology.
[12] Graeme Milligan,et al. Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers , 2006, The Journal of Neuroscience.
[13] J. Linden,et al. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. , 2005, The Biochemical journal.
[14] M. Rathbone,et al. Nucleoside transporter expression and function in cultured mouse astrocytes , 2005, Glia.
[15] S. Josselyn,et al. CREB, synapses and memory disorders: past progress and future challenges. , 2005, Current drug targets. CNS and neurological disorders.
[16] J. Zezula,et al. Heterotrimeric G Protein-independent Signaling of a G Protein-coupled Receptor , 2005, Journal of Biological Chemistry.
[17] M. Sitkovsky,et al. Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors , 2005, Nature Reviews Immunology.
[18] K. Fuxe,et al. Dimer-based model for heptaspanning membrane receptors. , 2005, Trends in biochemical sciences.
[19] A. Ohta,et al. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? , 2005, Trends in immunology.
[20] A. Ohta,et al. Oxygenation Inhibits the Physiological Tissue-Protecting Mechanism and Thereby Exacerbates Acute Inflammatory Lung Injury , 2005, PLoS biology.
[21] R. Cunha,et al. Adenosine A2A receptors control the extracellular levels of adenosine through modulation of nucleoside transporters activity in the rat hippocampus , 2005, Journal of neurochemistry.
[22] Ming-Chang Chiang,et al. cAMP-response Element-binding Protein Contributes to Suppression of the A2A Adenosine Receptor Promoter by Mutant Huntingtin with Expanded Polyglutamine Residues* , 2005, Journal of Biological Chemistry.
[23] M. Chiang,et al. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model , 2005, Journal of neurochemistry.
[24] S. Robson,et al. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. , 2005, Seminars in thrombosis and hemostasis.
[25] P. Lazzerini,et al. Upregulation of A2A adenosine receptor expression by TNF-alpha in PBMC of patients with CHF: a regulatory mechanism of inflammation. , 2005, Journal of cardiac failure.
[26] Courtney M. Lappas,et al. A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells1 , 2005, The Journal of Immunology.
[27] C. Print,et al. Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity , 2005, The Journal of experimental medicine.
[28] C. Diniz,et al. Facilitation of noradrenaline release by activation of adenosine A(2A) receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery. , 2004, Cardiovascular research.
[29] A. Prats,et al. Internal Ribosome Entry Site Structural Motifs Conserved among Mammalian Fibroblast Growth Factor 1 Alternatively Spliced mRNAs , 2004, Molecular and Cellular Biology.
[30] A. Ohta,et al. Cutting Edge: Physiologic Attenuation of Proinflammatory Transcription by the Gs Protein-Coupled A2A Adenosine Receptor In Vivo , 2004, The Journal of Immunology.
[31] M. Baba,et al. Upregulation of striatal adenosine A2A receptor mRNA in 6‐hydroxydopamine‐lesioned rats intermittently treated with L‐DOPA , 2004, Synapse.
[32] Manfred Thiel,et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. , 2004, Annual review of immunology.
[33] Z. Weng,et al. Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses , 2004, Brain Research.
[34] G. Semenza. O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. , 2004, Journal of applied physiology.
[35] Liping Huang,et al. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[36] G. Wong,et al. Adenosine A2A receptor mRNA expression is increased in rat striatum and nucleus accumbens after memantine administration. , 2004, Brain research. Molecular brain research.
[37] K. Fuxe,et al. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer , 2003, Journal of neurochemistry.
[38] M. Sitkovsky,et al. Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. , 2003, Blood.
[39] M. Roth,et al. ARNO and ARF6 regulate axonal elongation and branching through downstream activation of phosphatidylinositol 4-phosphate 5-kinase alpha. , 2003, Molecular biology of the cell.
[40] M. Chiang,et al. Characterization of the rat A2A adenosine receptor gene: a 4.8‐kb promoter‐proximal DNA fragment confers selective expression in the central nervous system , 2003, The European journal of neuroscience.
[41] F. Ciruela,et al. The Adenosine A2A Receptor Interacts with the Actin-binding Protein α-Actinin* , 2003, Journal of Biological Chemistry.
[42] B. Fredholm,et al. Signalling from adenosine receptors to mitogen-activated protein kinases. , 2003, Cellular signalling.
[43] R. Jaenisch,et al. HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.
[44] M. Sitkovsky. Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. , 2003, Biochemical pharmacology.
[45] H. Wong,et al. The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP‐1 cells , 2002, Journal of leukocyte biology.
[46] H. Shih,et al. Essential Role of cAMP-response Element-binding Protein Activation by A2A Adenosine Receptors in Rescuing the Nerve Growth Factor-induced Neurite Outgrowth Impaired by Blockage of the MAPK Cascade* , 2002, The Journal of Biological Chemistry.
[47] P. Greengard,et al. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine , 2002, Nature.
[48] J. Olson,et al. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. , 2002, Human molecular genetics.
[49] J. Olson,et al. Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. , 2002, Human molecular genetics.
[50] F. Pedata,et al. Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation. , 2002, European journal of pharmacology.
[51] Peter Carmeliet,et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[52] A. Ohta,et al. Differential Regulation of Two Alternatively Spliced Isoforms of Hypoxia-inducible Factor-1α in Activated T Lymphocytes* , 2001, The Journal of Biological Chemistry.
[53] A. Ohta,et al. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage , 2001, Nature.
[54] B. Fredholm,et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.
[55] P. Greengard. The neurobiology of slow synaptic transmission. , 2001, Science.
[56] B. Cronstein,et al. Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.
[57] H. Cho,et al. Differential usage of multiple brain-derived neurotrophic factor promoter in rat dorsal root ganglia following peripheral nerve injuries and inflammation. , 2001, Brain research. Molecular brain research.
[58] F. Lee,et al. Activation of Trk neurotrophin receptors in the absence of neurotrophins , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. Girault,et al. Gαolf is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum , 2001, Journal of neurochemistry.
[60] J. F. Chen,et al. Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice. , 2001, The Biochemical journal.
[61] B. Fredholm,et al. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. , 2001, Biochemical pharmacology.
[62] P. Svenningsson,et al. Adenosine A2A Receptors are Colocalized with and Activate Golf in Rat Striatum , 2000 .
[63] H. Zimmermann. Extracellular metabolism of ATP and other nucleotides , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[64] M. Montminy,et al. Characterization of a CREB Gain-of-Function Mutant with Constitutive Transcriptional Activity In Vivo , 2000, Molecular and Cellular Biology.
[65] M. Dragunow,et al. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease , 2000, Neuroscience.
[66] G. Semenza. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. , 2000, Journal of applied physiology.
[67] P. Greengard,et al. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[68] Y. Chern,et al. The 5' Untranslated Regions of the Rat A2A Adenosine Receptor Gene Function as Negative Translational Regulators , 1999, Journal of neurochemistry.
[69] P. Sassone-Corsi,et al. Signaling routes to CREM and CREB: plasticity in transcriptional activation. , 1999, Trends in biochemical sciences.
[70] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[71] S. Rivkees,et al. Characterization of the Murine A1 Adenosine Receptor Promoter, Potent Regulation by GATA-4 and Nkx2.5* , 1999, The Journal of Biological Chemistry.
[72] S. Kobayashi,et al. The dendritic translocation of translin protein in the form of BC1 RNA protein particles in developing rat hippocampal neurons in primary culture. , 1998, Biochemical and biophysical research communications.
[73] K. Mack,et al. Multiple promoters direct stimulus and temporal specific expression of brain-derived neurotrophic factor in the somatosensory cortex. , 1998, Brain research. Molecular brain research.
[74] T. Muramatsu,et al. BC1 RNA protein particles in mouse brain contain two y-,h-element-binding proteins, translin and a 37 kDa protein. , 1998, Biochemical and biophysical research communications.
[75] T. Stone,et al. Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists , 1998, Neuroscience.
[76] P. Greengard,et al. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons , 1998, Neuroscience.
[77] R. K. Shepherd,et al. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. , 1997, The Journal of clinical investigation.
[78] T. Dunwiddie,et al. Adenine Nucleotides Undergo Rapid, Quantitative Conversion to Adenosine in the Extracellular Space in Rat Hippocampus , 1997, The Journal of Neuroscience.
[79] Steve Huang,et al. Memory of Extracellular Adenosine A2A Purinergic Receptor-mediated Signaling in Murine T Cells* , 1997, The Journal of Biological Chemistry.
[80] Steve Huang,et al. Role of A2a Extracellular Adenosine Receptor-Mediated Signaling in Adenosine-Mediated Inhibition of T-Cell Activation and Expansion , 1997 .
[81] S. Schiffmann,et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.
[82] Y. Chern,et al. Protein Kinase C Inhibits Adenylyl Cyclase Type VI Activity during Desensitization of the A2a-Adenosine Receptor-mediated cAMP Response* , 1997, The Journal of Biological Chemistry.
[83] S. Chien,et al. Shear stress induction of the tissue factor gene. , 1997, The Journal of clinical investigation.
[84] M Kasai,et al. Isolation and characterization of a cDNA encoding a Translin‐like protein, TRAX , 1997, FEBS letters.
[85] Y. Chern,et al. Characterization of the rat A2a adenosine receptor gene. , 1996, DNA and cell biology.
[86] J. Gusella,et al. Characterization and Expression of the Human A2a Adenosine Receptor Gene , 1996, Journal of neurochemistry.
[87] F. Ciruela,et al. Immunological identification of A1 adenosine receptors in brain cortex , 1995, Journal of neuroscience research.
[88] B. Fredholm,et al. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices , 1995, Neurochemistry International.
[89] E. Mufson,et al. TrkA‐immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin , 1994, The Journal of comparative neurology.
[90] M. Caron,et al. Phosphorylation and Palmitoylation of the Human D2L Dopamine Receptor in Sf9 Cells , 1994, Journal of neurochemistry.
[91] G. Stiles,et al. Posttranscriptional mRNA processing as a mechanism for regulation of human A1 adenosine receptor expression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[92] O. Lindvall,et al. Brain Insults in Rats Induce Increased Expression of the BDNF Gene through Differential Use of Multiple Promoters , 1994, The European journal of neuroscience.
[93] M. Caron,et al. Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. , 1994, European journal of pharmacology.
[94] B. Fredholm,et al. Propentofylline and Other Adenosine Transport Inhibitors Increase the Efflux of Adenosine Following Electrical or Metabolic Stimulation of Rat Hippocampal Slices , 1994, Journal of neurochemistry.
[95] G. Stiles,et al. Characterization of the human A1 adenosine receptor gene. Evidence for alternative splicing. , 1994, The Journal of biological chemistry.
[96] D. Weaver. A2a adenosine receptor gene expression in developing rat brain. , 1993, Brain research. Molecular brain research.
[97] E. Arenas,et al. Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[98] B. Fredholm,et al. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion , 1993, Neurochemistry International.
[99] B. Fredholm,et al. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells. , 1990, Molecular pharmacology.
[100] B. Cronstein,et al. The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. , 1990, The Journal of clinical investigation.
[101] B. Fredholm,et al. Activation of protein kinase C inhibits prostaglandin‐ and potentiates adenosine receptor‐stimulated accumulation of cyclic AMP in a human T‐cell leukemia line , 1987, FEBS letters.
[102] B. Fredholm,et al. Release of Purines, Noradrenaline, and GABA from Rat Hippocampal Slices by Field Stimulation , 1985, Journal of neurochemistry.
[103] B. Fredholm,et al. Metabolism of adenosine and 2'-deoxy-adenosine by fetal mouse calvaria in culture. , 1982, Medical biology.
[104] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[105] T. Hökfelt,et al. Aspects on receptor regulation and isoreceptor identification. , 1980, Medical biology.
[106] P. Holton. The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves , 1959, The Journal of physiology.
[107] Luigi F. Agnati,et al. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function , 2007, Journal of Molecular Neuroscience.
[108] B. Cronstein,et al. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. , 2003, Arthritis and rheumatism.
[109] Michel Bouvier,et al. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.
[110] J. Linden. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.
[111] Katsunori Aoki,et al. Isolation and characterization of a cDNA encoding a Translin-like protein , 1997 .
[112] E. Newsholme,et al. The control of the metabolism and the hormonal role of adenosine. , 1978, Essays in biochemistry.